London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Application of Glautex implant in surgical treatment of primary open-angle glaucoma

Poster Details

First Author: S.Balalin RUSSIA

Co Author(s):    A. Schava   H. Abrosimova           

Abstract Details



Purpose:

To analyze efficiency of Glautex implant in surgical treatment of primary open-angle glaucoma

Setting:

The S.N. Fyodorov Eye Microsurgery Federal State Institution, Volgograd branch

Methods:

efficiency of surgical treatment was analyzed in 49 patients (21 males, 28 females) with POAG (55 eyes): 10 eyes with initial stage of disease, 16 eyes with developed and 29 eyes with advanced glaucoma. Mean patients' age was 67±0,5 years. Baseline preoperative intraocular pressure, measured according to Maklakov's method averaged 29,80,69 mm Hg (from 27 to 38 mm Hg). No intraoperative complications were registered.

Results:

one month postoperatively mean IOP equaled 18,20,59 mm Hg. Cutting out of the implant was observed in 4 cases (7,2 %) in immediate postoperative period. In was noted that drainage eruption was more common in cases when conjunctival incision was made too close to limbus. Within the 9 consecutive months uncomplicated goniopuncture of the Descemet's membrane was performed in 15 cases (27, 3%). Normalization of intraocular pressure was achieved. Nine months postoperatively mean IOP value was 20,20,8 mm Hg. In 16,4 % of cases (9 eyes) Glautex drainage remained in surgical zone for 6 months.

Conclusions:

sleeve-like Glautex draining system is efficient, provides the correct positioning and hypotensive effect in postoperative period. FINANCIAL INTEREST: NONE

Back to Poster listing